Cauldron Ferm
Cauldron Ferm is an Australian precision fermentation contract manufacturer that uses its proprietary continuous hyper-fermentation platform to help synthetic biology companies scale food proteins, functional ingredients, and bio-based products from laboratory to commercial production.
- Company typePrivate
- Founded2022
- HeadquartersOrange, Australia
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Cauldron Ferm does
Cauldron Ferm is an Australian precision fermentation biomanufacturing company founded in 2022 in Orange, NSW, that operates a contract manufacturing platform enabling synthetic biology companies to scale fermentation processes from laboratory to commercial production. The company's core offering is a proprietary "hyper-fermentation" continuous biomanufacturing technology — a continuous fermentation platform that addresses two chronic limitations of traditional fed-batch fermentation: contamination risk and genetic drift during extended runs. The platform is paired with ACE media, a set of fully defined, organism-specific nutrient formulations designed to prevent contamination in continuous culture. Together, these components underpin three tiered services: FermaFit (lab-scale technical fit evaluation), FermaValidate (10kL scale-up and techno-economic validation), and FermaGrow (commercial-scale production at 100kL+), with the company claiming 30-50% lower operational expenditure and 45% lower capital expenditure than incumbent batch fermentation.
The company monetizes primarily through multi-year enterprise contract manufacturing agreements, with a secondary stream from licensing its globally commercialized hyper-fermentation IP — acquired from Agritechnology in 2022, representing the product of 35 years of R&D. Pricing is quote-based across the three service tiers. The customer base is horizontal within synthetic biology — food protein developers, functional ingredient companies, and producers of animal-free compounds — with Nourish Ingredients (animal-free fats and proteins) disclosed as the first customer in 2023. Cauldron operates a 25,000-liter demonstration facility in Orange and is developing the Cauldron Bio-fab in Mackay, Queensland, intended to be Asia-Pacific's largest end-to-end precision fermentation contract manufacturer at 1,000+ tonnes/year.
The company has raised approximately $26 million in equity across four rounds (2023 seed, 2024 Series A, 2026 Series A2) led by Main Sequence Ventures and Horizons Ventures, with participation from SOSV, In-Q-Tel, and NGS Super. It has additionally secured roughly $8.9 million in non-dilutive government funding from the Australian Industry Growth Program, the U.S. Department of Defense, and Business.gov.au. Cauldron was recognized as a 2025 World Economic Forum Technology Pioneer and ranked #9 on Fast Company's Most Innovative Companies in Asia-Pacific 2026.
Cauldron Ferm firmographics
Firmographics- Name
- Cauldron Ferm
- Legal name
- Cauldron Molecules Pty Ltd
- Website
- https://cauldronferm.com
- Company type
- Private
- Founded year
- 2022
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Cauldron Ferm is an Australian precision fermentation contract manufacturer that uses its proprietary continuous hyper-fermentation platform to help synthetic biology companies scale food proteins, functional ingredients, and bio-based products from laboratory to commercial production.
- Ownership category
- akta.pro rank
Cauldron Ferm industry classification
Industry- Product category
- Precision Fermentation Contract Manufacturing
- NAICS
- Beverage Manufacturing (3121)
- SIC
- Beverages (2080)
- akta.pro primary industry
- Fermented/Probiotic Beverage Co-Packing (Kombucha, Kefir, Culture Drinks) (AFAFAIAG)
- akta.pro secondary industry
- Fermented Beverage Contract Manufacturing & Private Label (AFAFAHAJ)
Keywords
Where Cauldron Ferm is headquartered
LocationHeadquarters
- HQ city
- Orange
- HQ country
- Australia
- HQ region
- Oceania
Offices2 records
Markets served
Cauldron Ferm business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Technology or R&D, Operations, Personnel, Infrastructure, Marketing or Sales
Revenue model
- Contract Biomanufacturing Services: Fee-for-service contract manufacturing using proprietary hyper fermentation platform. Provides three service tiers: FermaFit (technology evaluation), FermaValidate (10kL validation), and FermaGrow (commercial-scale production at 100kL+).
- Technology Licensing: Licensing of proprietary hyper fermentation technology and IP acquired in 2022 seed round, now globally commercialized.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | FermaFit - Technology evaluation tier |
| Other | Multi-year contract | FermaValidate - 10kL validation tier |
| Other | Multi-year contract | FermaGrow - Commercial-scale production tier |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels4 records
Cauldron Ferm product offering
Product offeringCore offering
Cauldron Ferm provides contract biomanufacturing services for precision fermentation, scaling customer fermentation processes from laboratory to commercial volumes using a proprietary continuous hyper-fermentation platform. Services are delivered through three tiers — FermaFit (technology evaluation), FermaValidate (10kL scale validation), and FermaGrow (100kL+ commercial production) — and supported by ACE media and proprietary bioprocess protocols. The company also licenses its hyper-fermentation technology IP for global commercialization.
Product overview
Cauldron Ferm offers a platform-plus-services model for precision fermentation biomanufacturing. The core is its proprietary hyper-fermentation technology (continuous fermentation that solves contamination and genetic drift challenges), paired with ACE media (optimized growth media formulations). Services are delivered through three tiers: FermaFit (lab-scale technology transfer and technical fit evaluation), FermaValidate (10kL scale-up validation with techno-economic analysis), and FermaGrow (commercial-scale production at 100kL). The company operates demonstration facilities in Orange, NSW and is developing a commercial-scale facility in Mackay, Queensland.
Differentiator
Problem solved
Functional benefit
Brands
- FermaFit: Technology transfer and evaluation of technical fit service for customers to transfer their technology and assess compatibility with Cauldron's continuous fermentation process.
- FermaValidate
- FermaGrow
- Cauldron Bio-fab
Products and services
- FermaFit Technology transfer and evaluation service that assesses the technical fit of a customer's micro-organism with Cauldron's hyper-fermentation platform at lab-scale, including ACE media compatibility assessment. Targeted at precision fermentation companies beginning their scale-up journey.
- FermaValidate Scale-up validation service at 10,000-litre scale that optimizes hyper-fermentation conditions and validates the techno-economic benefits for a customer's specific micro-organism, including COGS and output projections at 100kL scale. Targeted at synthetic biology companies ready to validate production economics before commercial-scale commitment.
- FermaGrow Commercial-scale contract manufacturing service using hyper-fermentation to deliver low-cost production and commercial volumes at price parity with conventional products at 100,000-litre-plus capacity. Targeted at synthetic biology companies commercializing precision-fermented food proteins, ingredients, and other bio-based products.
Quantifiable outcome
- 30-50% reduction in operational costs compared to traditional batch fermentation
- +3 more outcomes
Companies that use Cauldron Ferm
Customer profileNamed customers1 record
Segments1 record
Ideal customer profiles2 records
Cauldron Ferm technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Cauldron Ferm partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and minor.
- Mackay BioFutures HubcorePartnership for bioeconomy development at Mackay facility location. Provides infrastructure access and ecosystem positioning for first industrial-scale hyper fermentation facility.
- Boston BioprocesscoreStrategic partnership for scaling from laboratory to manufacturing scale. Boston Bioprocess provides bioprocess engineering expertise and technical support for customer implementations using Cauldron's hyper fermentation platform.
- UNSW Founders 10x AcceleratorminorParticipated in UNSW Founders 10x Accelerator program during company formation. Provides startup ecosystem support, mentorship, and network access for early-stage development.
Scale indicators8 records
Recent moves8 records
Expansion highlights6 records
Cauldron Ferm competitors and assessment
Company assessmentDirect peers
- Culture Biosciences: US-based fermentation contract development and manufacturing organization offering bioreactor services from lab to pilot scale. Directly comparable to Cauldron's FermaFit and FermaValidate tiers in serving synbio companies needing external fermentation capacity.
- Solar Biotech: Precision fermentation CDMO providing end-to-end services from strain engineering to commercial manufacturing. Closely comparable CDMO business model targeting synbio customers needing scale-up support.
- Conagen: Vertically integrated synthetic biology company offering precision fermentation manufacturing services across food, flavor, fragrance, cosmetics, and pharma. Comparable as a precision fermentation CDMO with proprietary strain and process IP.
- Bota Bio: China-based synthetic biology platform combining strain engineering with fermentation scale-up and manufacturing services. Comparable CDMO offering targeting industrial precision fermentation customers.
Broad incumbents
- Ginkgo Bioworks: US-listed synthetic biology platform with cell engineering and fermentation capabilities acquired through Zymergen. Broad incumbent in the synbio space whose 'Foundry' competes for the same upstream customer pipeline as Cauldron.
- Codexis: US-listed enzyme engineering and biocatalysis company with proprietary fermentation and screening capabilities. Adjacent incumbent in industrial biomanufacturing serving pharma and food customers.
- BioVectra: North American CDMO with microbial fermentation capabilities serving pharma, food, and industrial biotech customers. Comparable established contract manufacturer that Cauldron's US facility would compete with regionally.
Emerging players
- Perfect Day: Animal-free dairy protein producer using precision fermentation. Comparable as a downstream precision fermentation customer/operator; overlaps with Cauldron on technology stack and customer segment but is also a potential FermaGrow customer rather than purely a competitor.
- LanzaTech: Carbon-capture gas fermentation company operating commercial-scale bioreactors. Comparable in scaling non-traditional continuous fermentation processes to industrial volumes and in winning government/defense funding.
Regional players
- Enzene Biosciences: India-based biologics and fermentation CDMO with continuous bioprocessing expertise. Comparable contract manufacturer with continuous manufacturing capabilities, primarily serving Asia-Pacific markets.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Cauldron Ferm social profiles
Digital presenceCauldron Ferm financial estimates
Financial estimateRevenue estimate
Valuation estimate
Cauldron Ferm leadership team
Management profileNumber of profiles
Profiles4 records
Cauldron Ferm funding detail
Funding detailFunding overview
Funding rounds6 records
Investors8 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Cauldron Ferm M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Cauldron Ferm
What does Cauldron Ferm do?
Cauldron Ferm provides contract biomanufacturing services for precision fermentation, scaling customer fermentation processes from laboratory to commercial volumes using a proprietary continuous hyper-fermentation platform. Services are delivered through three tiers — FermaFit (technology evaluation), FermaValidate (10kL scale validation), and FermaGrow (100kL+ commercial production) — and supported by ACE media and proprietary bioprocess protocols. The company also licenses its hyper-fermentation technology IP for global commercialization.
Is Cauldron Ferm a public or private company?
Cauldron Ferm is a private company. It is classified as venture growth investor backed and is currently operating.
When was Cauldron Ferm founded?
Cauldron Ferm was founded in 2022. It employs 11 to 50 people.
Where is Cauldron Ferm based?
Cauldron Ferm is headquartered in Orange, Australia, in the Oceania region.
How does Cauldron Ferm make money?
Two revenue lines are on record. Contract Biomanufacturing Services are the primary driver. The others are technology Licensing.
Who are Cauldron Ferm's main competitors?
Direct peers on record are Culture Biosciences, Solar Biotech, Conagen and Bota Bio. Broad incumbents are Ginkgo Bioworks, Codexis and BioVectra. Emerging players are Perfect Day and LanzaTech. Enzene Biosciences is listed as a regional player.
Does Cauldron Ferm have an API?
No public API is recorded for Cauldron Ferm.
What industry is Cauldron Ferm in?
Cauldron Ferm's product category is Precision Fermentation Contract Manufacturing. Its primary akta.pro industry code is AFAFAIAG, Fermented/Probiotic Beverage Co-Packing (Kombucha, Kefir, Culture Drinks), with a secondary code of AFAFAHAJ, Fermented Beverage Contract Manufacturing & Private Label. Its NAICS code is 3121 and its SIC code is 2080.